Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03975309 · ClinicalTrials.gov registry record
DHS MIND Metabolomics
A clinical trial of Diabetes, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 417
- Enrollment target
- 1
- Study location
NCT03975309 is a study of Diabetes that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 417 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03975309, a study of Diabetes, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 417 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will evaluate whether metabolomic signatures of neurocognitive decline trajectories are exacerbated by the presence of type 2 diabetes mellitus (T2D) and whether these signatures contribute in part, to ethnic disparities in cognitive decline between European Americans and African Americans with T2D.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2023-05-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03975309
The ClinicalTrials.gov registry entry for NCT03975309 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 417 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (86% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT03975309 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03975309 about?
NCT03975309 is a clinical study titled "DHS MIND Metabolomics". The study team will evaluate whether metabolomic signatures of neurocognitive decline trajectories are exacerbated by the presence of type 2 diabetes mellitus (T2D) and whether these signatures contribute in part, to ethnic disparities in cognitive decline between European Americans and African Amer...
What is the current status of trial NCT03975309?
This trial is currently completed. The enrollment target is 417 participants. The study started on 2019-09-09. Estimated completion is 2023-05-23.
What conditions does trial NCT03975309 study?
This clinical trial studies the following conditions: Diabetes.
Who is sponsoring clinical trial NCT03975309?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03975309 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.